Search images on Google      Product Monograph

Active Ingredients:

• galsulfase, 1 MG/ML

DIN: 02412683

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: 5MG/5ML. SINGLE USE VIAL.

Schedule: Schedule D

Company: BIOMARIN PHARMACEUTICAL INC.

ATC:

• A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, WHO, Wiki)
• A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, WHO)
• A16AB - Enzymes (ATC, WHO)
• A16AB08 - GALSUFASE (WHO)

Reference brand drug: Naglazyme

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 5ML

Pharmaceutical standard: MFR

 

External Links for Naglazyme:

Search on Google

• Naglazyme side effects
• Naglazyme dosage
• galsulfase side effects
• galsulfase dosage